Does TOFACITINIB Cause Sars-cov-2 test positive? 144 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Sars-cov-2 test positive have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
144
Reports of Sars-cov-2 test positive with TOFACITINIB
0.1%
of all TOFACITINIB reports
4
Deaths
18
Hospitalizations
How Dangerous Is Sars-cov-2 test positive From TOFACITINIB?
Of the 144 reports, 4 (2.8%) resulted in death, 18 (12.5%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Sars-cov-2 test positive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Sars-cov-2 test positive?
OCRELIZUMAB (1,421)
ADALIMUMAB (1,301)
DUPILUMAB (860)
NIRMATRELVIR\RITONAVIR (538)
LENALIDOMIDE (469)
SECUKINUMAB (378)
CERTOLIZUMAB PEGOL (361)
RISANKIZUMAB-RZAA (335)
RITUXIMAB (305)
UPADACITINIB (281)
Which TOFACITINIB Alternatives Have Lower Sars-cov-2 test positive Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN